Meta-analysis of radiotherapy on triple-negative breast cancer after breast conservation surgery
YANG Mei*, ZHANG Jian-qing, BAI Ge, ZHANG Li
*Second Department of Tumor Centre, First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, China Corresponding author:ZHANG Li, VIP Department of Internal Medicine, First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054, China;Email:zhangli9514@126.com
Abstract：Objective To systematically evaluate the influence of radiotherapy on triple-negative breast cancer (TNBC) patients treated with breast conservation surgery. Methods Electronic databases including PubMed, Ovid, CBM,ⅥP and CNKI and seven journals in Chinese (including the Chin J Breast Cancer, Chin J Clin Oncol, Chin J Radiat Oncol, Chin J Cancer, Chin J Oncol, J Pract Oncol and Tumor) were searched. Clinical trials comparing survival rates of patients with TNBC and non TNBC treated with breast conservation surgery and radiotherapy were reviewed. The quality assessment and data extraction were performed by two reviewers independently. RevMan5.1 software developed by the Cochrane collaboration was used for Meta-analysis. The 5-year distant metastasis-free survival (DMFS), overall survival (OS) and local recurrence-free survival (LRFS) rates were the primary end points. Results Five trials including 2345 patients with breast cancer were included in this systematic review.417 patients had TNBC and 1928 patients had non TNBC．Meta-analysis showed that the 5-year DMFS and OS rates of patients with TNBC were lower compared with non TNBC (Z=5.29,P=0.000 and Z=3.35,P=0.001). There was no statistical significant difference in 5-year LRFS rate between patients with TNBC and non TNBC (Z=1.35,P=0.180). Conclusion Radiotherapy provides good local control for patients with TNBC after breast conservation surgery.
YANG Mei*,ZHANG Jian-qing,BAI Ge et al. Meta-analysis of radiotherapy on triple-negative breast cancer after breast conservation surgery[J]. Chinese Journal of Radiation Oncology, 2012, 21(6): 531-533.
[1] Anders CK, Carey LA. Biology, metastatic patterns,and treatment of patients with triple-negative breast cancer. Clin Breast Cancer,2009,9 Suppl 2:73-81. [2] Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer:a critical review. J Clin Oncol,2008,26:2568-2581. [3] Haffty BG, Yang QF, Reiss M, et al. Loco regional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol,2006,24:5652-5657. [4] Solin LJ, Wei-Ting H, Vapiwala N. Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma. Clin Breast Cancer,2009,9:96-100. [5] Freedman GM, Anderson PR, Li TY, et al. Loco regional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer,2009,115:946-951. [6] Zaky SS, Lund MJ, May KA, et al. Triple negative breast cancer confers higher recurrence rates after breast conserving therapy. Radiat Oncol,2008,72:153-154. [7] Nguyen PL, Taghian LG, Katz MS, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol,2008,26:2373-3110. [8] Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumor. Nature,2000,406:747-752. [9] Cleator S, Heller W, Coombes RC. Triple-negative breast cancer:therapeutic options. Lancet Oncol,2007,8:235-244. [10] Abdulkarim BS, Cuartero J, Hanson J, et al. Increased risk of loco regional recurrence for women with T1－2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol,2011,29:2852-2858.
2012, Vol. 21 
